ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 194 filers reported holding ARRAY BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $67,612,000 | +105.9% | 1,462,833 | +8.6% | 0.01% | +85.7% |
| Q1 2019 | $32,845,000 | +1185.5% | 1,347,228 | +651.4% | 0.01% | +600.0% |
| Q4 2018 | $2,555,000 | -3.0% | 179,306 | +3.5% | 0.00% | 0.0% |
| Q3 2018 | $2,633,000 | +235.8% | 173,210 | +270.8% | 0.00% | – |
| Q2 2018 | $784,000 | +8.7% | 46,712 | +5.7% | 0.00% | – |
| Q1 2018 | $721,000 | +21.2% | 44,191 | -4.9% | 0.00% | – |
| Q4 2017 | $595,000 | -82.6% | 46,475 | -83.4% | 0.00% | -100.0% |
| Q3 2017 | $3,427,000 | +85.4% | 279,764 | +33.1% | 0.00% | – |
| Q4 2016 | $1,848,000 | +26.1% | 210,250 | -3.2% | 0.00% | – |
| Q3 2016 | $1,466,000 | +13227.3% | 217,183 | +7139.4% | 0.00% | – |
| Q2 2016 | $11,000 | -70.3% | 3,000 | -66.2% | 0.00% | – |
| Q4 2015 | $37,000 | -39.3% | 8,876 | -33.3% | 0.00% | – |
| Q3 2015 | $61,000 | -36.5% | 13,300 | 0.0% | 0.00% | – |
| Q2 2015 | $96,000 | -92.0% | 13,300 | -91.8% | 0.00% | – |
| Q1 2015 | $1,196,000 | +1768.8% | 162,351 | +1093.8% | 0.00% | – |
| Q4 2014 | $64,000 | +18.5% | 13,600 | +20.2% | 0.00% | – |
| Q1 2014 | $54,000 | -18.2% | 11,312 | -13.7% | 0.00% | – |
| Q4 2013 | $66,000 | -85.0% | 13,112 | -81.5% | 0.00% | – |
| Q3 2013 | $440,000 | -23.6% | 70,773 | -44.2% | 0.00% | – |
| Q2 2013 | $576,000 | – | 126,827 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |